Literature DB >> 22406839

The hinge region in androgen receptor control.

Liesbeth Clinckemalie1, Dirk Vanderschueren, Steven Boonen, Frank Claessens.   

Abstract

The region between the DNA-binding domain and the ligand-binding domain of nuclear receptors is termed the hinge region. Although this flexible linker is poorly conserved, diverse functions have been ascribed to it. For the androgen receptor (AR), the hinge region and in particular the (629)RKLKKL(634) motif, plays a central role in controlling AR activity, not only because it acts as the main part of the nuclear translocation signal, but also because it regulates the transactivation potential and intranuclear mobility of the receptor. It is also a target site for acetylation, ubiquitylation and methylation. The interplay between these different modifications as well as the phosphorylation at serine 650 will be discussed here. The hinge also has an important function in AR binding to classical versus selective androgen response elements. In addition, the number of coactivators/corepressors that might act via interaction with the hinge region is still growing. The importance of the hinge region is further illustrated by the different somatic mutations described in patients with androgen insensitivity syndrome and prostate cancer. In conclusion, the hinge region serves as an integrator for signals coming from different pathways that provide feedback to the control of AR activity.
Copyright © 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22406839     DOI: 10.1016/j.mce.2012.02.019

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  40 in total

1.  Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.

Authors:  Christine Helsen; Vanessa Dubois; Annelien Verfaillie; Jacques Young; Mieke Trekels; Renée Vancraenenbroeck; Marc De Maeyer; Frank Claessens
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 2.  Activation of PPARδ: from computer modelling to biological effects.

Authors:  Shirin Kahremany; Ariela Livne; Arie Gruzman; Hanoch Senderowitz; Shlomo Sasson
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 3.  New Opportunities for Targeting the Androgen Receptor in Prostate Cancer.

Authors:  Margaret M Centenera; Luke A Selth; Esmaeil Ebrahimie; Lisa M Butler; Wayne D Tilley
Journal:  Cold Spring Harb Perspect Med       Date:  2018-12-03       Impact factor: 6.915

Review 4.  Androgen receptor: what we know and what we expect in castration-resistant prostate cancer.

Authors:  Zhonglin Cai; Weijie Chen; Jianzhong Zhang; Hongjun Li
Journal:  Int Urol Nephrol       Date:  2018-08-20       Impact factor: 2.370

Review 5.  Androgen receptor variation affects prostate cancer progression and drug resistance.

Authors:  Edel McCrea; Tristan M Sissung; Douglas K Price; Cindy H Chau; William D Figg
Journal:  Pharmacol Res       Date:  2016-10-07       Impact factor: 7.658

6.  Androgen receptor splice variants determine taxane sensitivity in prostate cancer.

Authors:  Maria Thadani-Mulero; Luigi Portella; Shihua Sun; Matthew Sung; Alexandre Matov; Robert L Vessella; Eva Corey; David M Nanus; Stephen R Plymate; Paraskevi Giannakakou
Journal:  Cancer Res       Date:  2014-02-20       Impact factor: 12.701

Review 7.  Polyglutamine androgen receptor-mediated neuromuscular disease.

Authors:  Elisa Giorgetti; Andrew P Lieberman
Journal:  Cell Mol Life Sci       Date:  2016-05-17       Impact factor: 9.261

Review 8.  Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer.

Authors:  Navid Sobhani; Daniele Generali; Alberto D'Angelo; Michele Aieta; Giandomenico Roviello
Journal:  Invest New Drugs       Date:  2018-08-07       Impact factor: 3.850

9.  Hic-5 is a transcription coregulator that acts before and/or after glucocorticoid receptor genome occupancy in a gene-selective manner.

Authors:  Rajas Chodankar; Dai-Ying Wu; Benjamin J Schiller; Keith R Yamamoto; Michael R Stallcup
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

10.  Bisphenol A affects androgen receptor function via multiple mechanisms.

Authors:  Christina Teng; Bonnie Goodwin; Keith Shockley; Menghang Xia; Ruili Huang; John Norris; B Alex Merrick; Anton M Jetten; Christopher P Austin; Raymond R Tice
Journal:  Chem Biol Interact       Date:  2013-04-04       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.